[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in the first nine months – outlook for 2021 raised
Basel, 20 October 2021 Group sales up 8%1 at constant exchange rates (CER); 6% in Swiss francs Pharmaceuticals Division sales grow 5% in the third quarter and are now in line with the prior year for the first nine months; continued strong growth of newly launched medicines Diagnostics Division sales grow 18% in the third... Read more